We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$26.8B
AUM Growth
+$3.09B
Cap. Flow
+$1.26B
Cap. Flow %
4.69%
Top 10 Hldgs %
40.07%
Holding
1,108
New
38
Increased
406
Reduced
634
Closed
28

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$209M
2
MCHP icon
Microchip Technology
MCHP
+$129M
3
ADI icon
Analog Devices
ADI
+$119M
4
QCOM icon
Qualcomm
QCOM
+$112M
5
TXN icon
Texas Instruments
TXN
+$108M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$309M
2
NVDA icon
NVIDIA
NVDA
+$93.3M
3
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$78.6M
4
FXI icon
iShares China Large-Cap ETF
FXI
+$69.7M
5
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$35M

Sector Composition

Rank Sector Weight
1 Technology 47.45%
2 Financials 9.33%
3 Healthcare 6.2%
4 Consumer Discretionary 3.62%
5 Energy 2.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
276
Madrigal Pharmaceuticals
MDGL
$11.1B
$9.59M 0.04%
35,917
-7,182
-17% -$1.69M
T icon
277
AT&T
T
$162B
$9.55M 0.04%
542,830
-11,964
-2% -$204K
PB icon
278
Prosperity Bancshares
PB
$9.02B
$9.55M 0.04%
145,129
-12,002
-8% -$765K
SRPT icon
279
Sarepta Therapeutics
SRPT
$1.68B
$9.55M 0.04%
73,739
-29,414
-29% -$3.6M
KRYS icon
280
Krystal Biotech
KRYS
$9.21B
$9.5M 0.04%
53,367
-30,654
-36% -$4.26M
RYTM icon
281
Rhythm Pharmaceuticals
RYTM
$7.04B
$9.47M 0.04%
218,657
+97,003
+80% +$4.25M
PNFP icon
282
Pinnacle Financial Partners Inc
PNFP
$16.2B
$9.44M 0.04%
109,874
-1,138
-1% -$95.6K
BPMC
283
DELISTED
Blueprint Medicines
BPMC
$9.42M 0.04%
99,351
-22,017
-18% -$1.89M
NTRA icon
284
Natera
NTRA
$38.7B
$9.42M 0.04%
102,975
-51,429
-33% -$3.87M
CERE
285
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$9.4M 0.04%
222,314
+80,837
+57% +$3.4M
FITB
286
Fifth Third Bancorp
FITB
$51.6B
$9.39M 0.04%
252,464
+11,067
+5% +$385K
IMVT icon
287
Immunovant
IMVT
$7.9B
$9.35M 0.03%
289,385
+60,298
+26% +$2.2M
EQT icon
288
EQT Corp
EQT
$33.5B
$9.35M 0.03%
252,092
-45,254
-15% -$1.62M
BMRN icon
289
BioMarin Pharmaceuticals
BMRN
$11.6B
$9.32M 0.03%
106,697
+10,098
+10% +$904K
BLD
290
DELISTED
TopBuild
BLD
$9.31M 0.03%
21,122
-1,769
-8% -$692K
NKE icon
291
Nike
NKE
$63.2B
$9.31M 0.03%
99,015
-4,081
-4% -$415K
ALPN
292
DELISTED
Alpine Immune Sciences Inc
ALPN
$9.3M 0.03%
234,625
+154,463
+193% +$4.56M
EQIX icon
293
Equinix
EQIX
$102B
$9.28M 0.03%
11,243
-1,348
-11% -$1.13M
RVMD icon
294
Revolution Medicines
RVMD
$38.8B
$9.16M 0.03%
284,352
-80,743
-22% -$2.39M
ALNY icon
295
Alnylam Pharmaceuticals
ALNY
$29.5B
$9.15M 0.03%
61,206
+8,398
+16% +$1.4M
NBIX icon
296
Neurocrine Biosciences
NBIX
$16.7B
$9.08M 0.03%
65,870
-10,679
-14% -$1.46M
IONS icon
297
Ionis Pharmaceuticals
IONS
$9.06B
$9.04M 0.03%
208,469
+24,073
+13% +$1.15M
APA icon
298
APA Corp
APA
$13B
$9.03M 0.03%
262,607
-22,112
-8% -$701K
TOL icon
299
Toll Brothers
TOL
$14.1B
$9.02M 0.03%
69,702
-7,733
-10% -$841K
SO icon
300
Southern Company
SO
$107B
$9M 0.03%
125,490
+3,814
+3% +$263K
10 11
12
13 14

Similar funds

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Rafferty Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Rafferty Asset Management held 1,108 positions worth $26.8B, up 13% from $23.7B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Rafferty Asset Management deployed $1.26B of net new capital in Q1 2024, opening 38 new positions and adding to 406 existing holdings. Its largest new stake was Super Micro Computer: 164,060 shares worth $16.6M.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 40% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $309M trimmed.

  • Rafferty Asset Management's largest Q1 2024 buy was Super Micro Computer: 164,060 shares worth $16.6M.
  • Rafferty Asset Management added most to Intel in Q1 2024, an estimated $209M increase.
  • Rafferty Asset Management's biggest Q1 2024 reduction was iShares Russell 2000 ETF, cutting an estimated $309M.
  • Rafferty Asset Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $13.8M.
  • Rafferty Asset Management's ten largest holdings make up 40% of its $26.8B portfolio in Q1 2024.
  • Rafferty Asset Management opened 38 new positions and closed 28 in Q1 2024.
  • Rafferty Asset Management's portfolio value rose 13% quarter-over-quarter to $26.8B.

Based on Rafferty Asset Management's 13F filing for Q1 2024, filed 13 May 2024.